SEARCH

SEARCH BY CITATION

References

  • 1
    Kohler BA, Ward E, McCarthy BJ, et al. Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 2011; 103: 71436.
  • 2
    Qiu D, Katanoda K, Marugame T, et al. A Joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958–2004). Int J Cancer 2009; 124: 4438.
  • 3
    Levi F, Lucchini F, Negri E, et al. Trends in mortality from leukemia in subsequent age groups. Leukemia 2000; 14: 19805.
  • 4
    Wayne AS, Reaman GH, Helman LJ. Progress in the curative treatment of childhood hematologic malignancies. J Natl Cancer Inst 2008; 100: 12713.
  • 5
    La Vecchia C, Bosetti C, Lucchini F, et al. Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol 2010; 21: 132360.
  • 6
    Bosetti C, Bertuccio P, Chatenoud L, et al. Childhood cancer mortality in Europe, 1970–2007. Eur J Cancer 2010; 46: 38494.
  • 7
    World Health Organization Statistical Information System. WHO mortality database Available at: http://www3.who.int/whosis/menu.cfm. Last accessed on April 2011.
  • 8
    World Health Organization. International Classification of Disease, 8th revision edn. Geneva: World Health Organization, 1967.
  • 9
    World Health Organization. International Classification of Disease, 9th revision edn. Geneva: World Health Organization, 1977.
  • 10
    World Health Organization. International statistical classification of disease and related health problems, 10th revision edn. Geneva: World Health Organization, 1992.
  • 11
    Doll R, Smith PG. Comparison between registries: age-standardized rates. vol. IV. IARC Sci Publ No. 42. In: Waterhouse JAH, Muir CS, Shanmugaratnam K, Powell J, Peacham D, Whelan S, eds. Cancer incidence in five continents. Lyon: IARC, 1982. 6715.
  • 12
    National Cancer Institute. Joinpoint Regression Program, version 3.5. Available at: http://srab.cancer.gov/joinpoint. Last accessed on April 2011.
  • 13
    Kim HJ, Fay MP, Feuer EJ, et al Permutation tests for joinpoint regression with applications to cancer rates. (Erratum in: Stat Med 2001; 20: 655). Stat Med 2000; 19: 335–51.
  • 14
    Clegg LX, Hankey BF, Tiwari R, et al. Estimating average annual per cent change in trend analysis. Stat Med 2009; 28: 367082.
  • 15
    Malvezzi M, Arfé A, Bertuccio P, et al. European cancer mortality predictions for the year 2011. Ann Oncol 2010; 22: 94756.
  • 16
    European Commission. Eurostat population database. Available at: http://epp.eurostat.ec.europa.eu/portal/portal/page/portal/eurostat/home/. Last accessed on October 2010.
  • 17
    Klepin HD, Balducci L. Acute myelogenous leukemia in older adults. Oncologist 2009; 14: 22232.
  • 18
    Balducci L. The geriatric cancer patient: equal benefit from equal treatment. Cancer Control 2001; 8: 125; quiz 7–8.
  • 19
    Levi F, Lucchini F, Negri E, et al. Changed trends of cancer mortality in the elderly. Ann Oncol 2001; 12: 146777.
  • 20
    Juliusson G, Karlsson K, Lazarevic VLj, et al. Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: real-world population-based data from the Swedish Acute Leukemia Registry 1997–2006. Cancer 2011; 117: 423846.
  • 21
    Boyle P, Levin B. Leukaemias. In: Boyle P, Levin B, eds. World Cancer Report 2008. World Health Organization. Lyon, France: International Agency for Research on Cancer, 2008. 47480.
  • 22
    Fielding AK, Goldstone AH. Allogeneic haematopoietic stem cell transplant in Philadelphia-positive acute lymphoblastic leukaemia. Bone Marrow Transplant 2008; 41: 44753.
  • 23
    Pidala J, Djulbegovic B, Anasetti C, et al. Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission. Cochrane Database Syst Rev 2011: CD008818.
  • 24
    Popat U, Carrum G, Heslop HE. Haemopoietic stem cell transplantation for acute lymphoblastic leukaemia. Cancer Treat Rev 2003; 29: 310.
  • 25
    Chan KW. Acute lymphoblastic leukemia. Curr Probl Pediatr Adolesc Health Care 2002; 32: 409.
  • 26
    Estey EH. How to manage high-risk acute myeloid leukemia. Leukemia 2011;26:861–9.
  • 27
    Jabbour E, Cortes JE, Giles FJ, et al. Current and emerging treatment options in chronic myeloid leukemia. Cancer 2007; 109: 217181.
  • 28
    Goldman JM, Melo JV. Chronic myeloid leukemia—advances in biology and new approaches to treatment. N Engl J Med 2003; 349: 145164.
  • 29
    Kantarjian H, O'Brien S, Jabbour E, et al. Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience. Blood 2012; 119: 19817.
  • 30
    Breccia M, Tiribelli M, Alimena G. Tyrosine kinase inhibitors for elderly chronic myeloid leukemia patients: a systematic review of efficacy and safety data. Crit Rev Oncol Hematol 2012. PMID: 22280914.
  • 31
    Abrisqueta P, Pereira A, Rozman C, et al. Improving survival in patients with chronic lymphocytic leukemia (1980–2008): the Hospital Clinic of Barcelona experience. Blood 2009; 114: 204450.
  • 32
    Brenner H, Gondos A, Pulte D. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood 2008; 111: 491621.
  • 33
    van den Broek E, Kater P, van de Schans S, et al. Chronic lymphocytic leukaemia in the Netherlands: trends in incidence, treatment and survival, 1989–2008. Eur J Cancer 2012; 48: 88995.
  • 34
    Auer RL, Gribben J, Cotter FE. Emerging therapy for chronic lymphocytic leukaemia. Br J Haematol 2007; 139: 63544.
  • 35
    Sant M, Allemani C, Santaquilani M, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 2009; 45: 93191.
  • 36
    Chatenoud L, Bertuccio P, Bosetti C, et al. Childhood cancer mortality in America, Asia, and Oceania, 1970 through 2007. Cancer 2010; 116: 506374.